We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





Abbott Showcases Innovations, Helps Labs Solve Health Care Challenges

By LabMedica International staff writers
Posted on 29 Jul 2014
Clinical laboratories around the world are helping to improve patient care while navigating an evolving health care environment. More...
Abbott (Abbott Park, IL, USA) will present more than 40 scientific presentations and/or posters related to the company's solutions to these challenges. A complete list of Abbott's presentations, posters and workshops can be found online (please see Related Links below). The company is developing diagnostic solutions, which it will showcase during the American Association for Clinical Chemistry (AACC 2014) annual meeting and clinical lab expo.

During the AACC meeting, Abbott will feature a variety of innovations focused on increased testing volumes and improving efficiencies: for the core lab, Abbott recently launched a next generation automation solution, the Acceleratora3600, which doubles per-hour processing capacity compared to previous systems. Studies have shown a core lab can eliminate a significant percentage of associated operating costs through automation and standardization of testing. Abbott's m2000 RealTime System for automated infectious disease molecular testing gives labs the ability to handle greater volumes at reduced costs on a single platform. Labs that use Abbott's molecular automated solutions may process the same number of tests with fewer instruments.

Used at a patient's bedside, the i-STAT point-of-care (POC) system allows physicians and nurses to quickly and accurately analyze lab-quality results within minutes, rather than hours, to accelerate decision-making and ensure patients receive the most effective and efficient care.

Abbott provides laboratories with a powerful suite of informatics solutions to manage large volumes of data across health care systems, helping labs simplify complex processes to make information actionable. Hospitals, reference labs, and blood banks use Abbott's informatics technology to help treat and monitor various diseases and medical conditions.

Related Links:

Abbott
Abbott Diagnostics



New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: AI-powered ctDNA analysis provides clinicians with a new lens to monitor disease evolution (Photo courtesy of Brandon Stelter, Katie Han, Kyle Smith, and Paul Northcott)

AI-Powered Liquid Biopsy Classifies Pediatric Brain Tumors with High Accuracy

Liquid biopsies offer a noninvasive way to study cancer by analyzing circulating tumor DNA in body fluids. However, in pediatric brain tumors, the small amount of ctDNA in cerebrospinal fluid has limited... Read more

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Pathology

view channel
Image: Sophie Paczesny, M.D., Ph.D and her team have made BIOPREVENT freely available for researchers and clinician to test and learn from (Photo courtesy of Cliff Rhodes)

AI Tool Uses Blood Biomarkers to Predict Transplant Complications Before Symptoms Appear

Stem cell and bone marrow transplants can be lifesaving, but serious complications may arise months after patients leave the hospital. One of the most dangerous is chronic graft-versus-host disease, in... Read more

Industry

view channel
Image: QuidelOrtho has entered into a strategic supply agreement with Lifotronic to expand its global immunoassay portfolio (Photo courtesy of QuidelOrtho)

QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio

QuidelOrtho (San Diego, CA, USA) has entered a long-term strategic supply agreement with Lifotronic Technology (Shenzhen, China) to expand its global immunoassay portfolio and accelerate customer access... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.